PREP Act: Pharmacists Can Administer COVID-19 Therapeutics
Jason Ausili, PharmD, the Chief Clinical Officer of FDS Amplicare, discusses the impact on community pharmacies and patients of the recent announcement by the HHS regarding the amendment to the COVID-19 PREP Act.
Jason Ausili, PharmD, the Chief Clinical Officer of FDS Amplicare, discusses the impact on community pharmacies and patients of the recent announcement by the HHS regarding the amendment to the COVID-19 PREP Act declaration to allow licensed pharmacists to order and administer select COVID-19 therapeutics, including subcutaneous monoclonal antibodies.
He addresses what was changed in the recent amendment, what role pharmacy technicians play in regards to this amendment, and how the amendment will impact the future of the pharmacy’s role within the healthcare system.
